Complete National Bank of Ras Al-Khaimah P.S.C. stock information by Barron's. View real-time RAKBANK stock price and news, along with industry-best analysis.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Academy for Continued Healthcare Learning is ...

The RPSC has announced the RAS mains result 2025, with 2,461 candidates declared successful. The mains exam was held on June 17 and 18, 2025, across multiple centres in Rajasthan in two shifts daily.

The top job in Pakistani higher education is, by design, a temporary one. The chairperson of the Higher Education Commission (HEC) now gets a mere two years — instead of four — to steward the ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

A meeting of the search committee regarding the appointment of a permanent Chairman of the Higher Education Commission (HEC) was held on Wednesday, while Education Secretary Nadeem Mahbub has assumed ...

The Higher Education Commission (HEC) of Pakistan has launched a major digital transformation initiative to improve public universities across the country. This project aims to replace old, ...

While the system has the "ingredients" necessary for top-tier university rankings, poor governance remains a significant barrier to progress, Chairman of the Higher Education Commission (HEC) Dr ...

A local court in Islamabad ordered the reinstatement of Dr Ziaul Qayyum as Executive Director of the Higher Education Commission (HEC). However, despite the court's orders, the HEC administration did ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.